Medivir
Sweden - HuddingeBiotechnology
Focus: Medivir is a Swedish biotech company focused on small-molecule drug development primarily in oncology and infectious disease. The company operates at mid-stage development with a diverse pipeline across multiple therapeutic areas.
Profile data last refreshed Yesterday · AI intelligence enriched 1w ago
Open Jobs
0
About Medivir
AI assessmentNot HiringNo open roles listed right now. Follow Medivir to get notified when they start hiring — the background below is worth knowing for when they do.
Why Work Here
Data completeness
1/9 — Limited
Company HealthStrong
Pipeline
Late-stage
3 Phase 3+
LOE Risk
Protected
No near-term cliffs
Hiring
0 open
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Pipeline & Clinical Trials
MIV-711
HealthyClinical Trials (1)
NCT03443453A Bioavailability Study of MIV-711 Oral Formulations in Healthy Volunteers
Phase 1Help build intelligence for Medivir
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.